share_log

Piper Sandler Maintains Overweight on Black Diamond Therapeutic, Raises Price Target to $15

Benzinga ·  Sep 24 02:01  · Ratings

Piper Sandler analyst Joseph Catanzaro maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Overweight and raises the price target from $12 to $15.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment